S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Closing prices for crude oil, gold and other commodities
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
United Airlines Soars on Earnings Beat

BioNTech (BNTX) SEC Filings & 10K Form

$86.40
+0.06 (+0.07%)
(As of 04/17/2024 ET)

Recent BioNTech SEC Filings

DateFilerForm TypeView
04/08/2024
4:05 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
6:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:57 AM
BioNTech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/20/2024
6:33 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:11 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:04 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
7:41 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:26 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
6:26 AM
BioNTech (Subject)
Medine GmbH (Filed by)
Form SC 13G/A
02/08/2024
5:08 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:03 PM
ATHOS KG (Filed by)
BioNTech (Subject)
Form SC 13G/A
01/31/2024
6:47 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
8:14 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
6:01 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
7:02 AM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:22 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
7:17 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
7:03 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
5:52 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
5:54 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2023
3:16 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2023
5:03 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2023
5:14 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2023
4:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144/A
09/29/2023
4:11 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
4:18 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144/A
08/14/2023
7:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2023
7:02 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2023
5:06 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
7:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2023
3:52 PM
BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
6:09 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
4:20 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
4:26 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2023
3:41 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
7:48 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
7:51 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2023
6:43 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
8:22 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
5:56 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
5:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BNTX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners